CD22 is expressed on the cell surface of the majority of BCP-ALL; among 163 pediatric patients with R/R BCP-ALL, CD22 was detected on at least 90% of blasts in 155 cases (95%). This evidence concerns the gene CD22 and acute lymphoblastic leukemia.